Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study

BACKGROUND: Vedolizumab has become a standard treatment for the inflammatory bowel diseases ulcerative colitis (UC) and Crohn’s disease (CD). However, there is an ongoing debate on the ideal individual treatment algorithms and means to predict treatment response are not routinely established. AIMS:...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Gastroenterol
Päätekijät: Mühl, Laura, Becker, Emily, Müller, Tanja M., Atreya, Raja, Atreya, Imke, Neurath, Markus F., Zundler, Sebastian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821503/
https://ncbi.nlm.nih.gov/pubmed/33482730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-021-01604-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia